panipenem-betamipron has been researched along with Experimental Pneumococcal Meningitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishiwada, N; Nakamoto, T; Ohkusu, M; Sato, J; Shoji, T; Takahashi, K; Takei, H; Takeuchi, N; Yamada, N | 1 |
| Haruta, T; Kobayashi, Y; Kuroki, S; Naramura, M; Nikami, H; Nishio, T; Ohkura, K | 1 |
1 trial(s) available for panipenem-betamipron and Experimental Pneumococcal Meningitis
| Article | Year |
|---|---|
[Studies on efficacy and safety of panipenem/betamipron against infections in pediatrics and on its movement to cerebrospinal fluid including cases of penicillin-resistant Streptococcus pneumoniae meningitis].
Topics: Age Factors; Bacterial Infections; beta-Alanine; Child, Preschool; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Infant; Infusions, Intravenous; Male; Meningitis, Pneumococcal; Penicillin Resistance; Suppuration; Thienamycins | 1992 |
1 other study(ies) available for panipenem-betamipron and Experimental Pneumococcal Meningitis
| Article | Year |
|---|---|
Two cases of bacterial meningitis due to meropenem-resistant Streptococcus pneumoniae: A threat of serotype 35B, ST 558 lineage.
Topics: Anti-Bacterial Agents; beta-Alanine; Cefotaxime; Drug Resistance, Multiple, Bacterial; Female; Humans; Infant; Male; Meningitis, Pneumococcal; Meropenem; Microbial Sensitivity Tests; Multilocus Sequence Typing; Pneumococcal Vaccines; Serotyping; Streptococcus pneumoniae; Thienamycins; Treatment Outcome | 2020 |